4735 related articles for article (PubMed ID: 16157765)
21. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
22. [Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases].
Shestakova MV; Butrova SA; Sukhareva OIu
Ter Arkh; 2007; 79(10):5-8. PubMed ID: 18154136
[No Abstract] [Full Text] [Related]
23. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome.
Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation.
Ford ES; Li C; Zhao G; Pearson WS; Mokdad AH
Diabetes Care; 2008 Mar; 31(3):587-9. PubMed ID: 18071007
[TBL] [Abstract][Full Text] [Related]
26. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
Battista M; Murray RD; Daniels SR
Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
[TBL] [Abstract][Full Text] [Related]
27. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
Lund SS; Vaag AA
Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
[No Abstract] [Full Text] [Related]
28. Controversy in diagnosis and management of the metabolic syndrome.
Brietzke SA
Med Clin North Am; 2007 Nov; 91(6):1041-61, vii-viii. PubMed ID: 17964908
[TBL] [Abstract][Full Text] [Related]
29. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
Haffner SM
Am J Med; 2006 May; 119(5 Suppl 1):S3-9. PubMed ID: 16563945
[TBL] [Abstract][Full Text] [Related]
30. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
[No Abstract] [Full Text] [Related]
31. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
32. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
33. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
[TBL] [Abstract][Full Text] [Related]
35. American Federation for Clinical Research position statement regarding the proposal to create a National Institute for Kidney and Urologic Diseases within the National Institutes of Health.
Clin Res; 1990 Apr; 38(2):236-8. PubMed ID: 2338022
[No Abstract] [Full Text] [Related]
36. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
37. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance syndrome in children.
Scott LK
Pediatr Nurs; 2006; 32(2):119-24, 143. PubMed ID: 16719421
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
; Bonadonna R; Cucinotta D; Fedele D; Riccardi G; Tiengo A
Diabetes Care; 2006 Dec; 29(12):2701-7. PubMed ID: 17130208
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
